{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:25:49Z","timestamp":1787135149514,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12664-025-01945-7","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:33:55Z","timestamp":1772944435000},"page":"816-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of albumin-bilirubin grade in patients with pancreatic cancer: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Mahyaar","family":"Omouri-Kharashtomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Menbari Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Mahdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-1901","authenticated-orcid":false,"given":"Amir","family":"Anushiravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"6","key":"1945_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1945_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/gutjnl-2018-316151","volume":"67","author":"A Scarpa","year":"2018","unstructured":"Scarpa A, Real FX, Luchini C. Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management. Gut. 2018;67:1561\u20133. https:\/\/doi.org\/10.1136\/gutjnl-2018-316151.","journal-title":"Gut"},{"issue":"1","key":"1945_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7\u201330. https:\/\/doi.org\/10.3322\/caac.21442.","journal-title":"CA Cancer J Clin"},{"issue":"10242","key":"1945_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/s0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"5","key":"1945_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10147-012-0474-9","volume":"18","author":"F Tas","year":"2013","unstructured":"Tas F, Sen F, Odabas H, K\u0131l\u0131c L, Kesk\u0131n S, Y\u0131ld\u0131z I. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. Int J Clin Oncol. 2013;18:839\u201346. https:\/\/doi.org\/10.1007\/s10147-012-0474-9.","journal-title":"Int J Clin Oncol"},{"issue":"9","key":"1945_CR6","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ijc.22535","volume":"120","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120:1993\u20138. https:\/\/doi.org\/10.1002\/ijc.22535.","journal-title":"Int J Cancer"},{"issue":"22","key":"1945_CR7","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","volume":"294","author":"RZ Stolzenberg-Solomon","year":"2005","unstructured":"Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA. 2005;294:2872\u20138. https:\/\/doi.org\/10.1001\/jama.294.22.2872.","journal-title":"JAMA"},{"issue":"11","key":"1945_CR8","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1245\/s10434-008-0148-z","volume":"15","author":"RA Smith","year":"2008","unstructured":"Smith RA, Dajani K, Dodd S, et al. Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2008;15:3138\u201346. https:\/\/doi.org\/10.1245\/s10434-008-0148-z.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1945_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200\u201310. https:\/\/doi.org\/10.1056\/NEJMoa032295.","journal-title":"N Engl J Med"},{"issue":"9","key":"1945_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jama.299.9.1019","volume":"299","author":"WF Regine","year":"2008","unstructured":"Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019\u201326. https:\/\/doi.org\/10.1001\/jama.299.9.1019.","journal-title":"JAMA"},{"issue":"4\u20135","key":"1945_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1159\/000320099","volume":"28","author":"A Thomas","year":"2010","unstructured":"Thomas A, Dajani K, Neoptolemos JP, Ghaneh P. Adjuvant therapy in pancreatic cancer. Dig Dis. 2010;28:684\u201392. https:\/\/doi.org\/10.1159\/000320099.","journal-title":"Dig Dis"},{"issue":"10","key":"1945_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073\u201381. https:\/\/doi.org\/10.1001\/jama.2010.1275.","journal-title":"JAMA"},{"issue":"12","key":"1945_CR13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1111\/j.1440-1746.2009.05935.x","volume":"24","author":"YC Kim","year":"2009","unstructured":"Kim YC, Kim HJ, Park JH, et al. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? J Gastroenterol Hepatol. 2009;24:1869\u201375. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05935.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1945_CR14","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.06.1483","volume":"73","author":"WS Koom","year":"2009","unstructured":"Koom WS, Seong J, Kim YB, Pyun HO, Song SY. CA 19\u20139 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:1148\u201354. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1483.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1945_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.bjc.6604568","volume":"99","author":"DD Stocken","year":"2008","unstructured":"Stocken DD, Hassan AB, Altman DG, et al. Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer. 2008;99:883\u201393. https:\/\/doi.org\/10.1038\/sj.bjc.6604568.","journal-title":"Br J Cancer"},{"issue":"6","key":"1945_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/jco.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138. https:\/\/doi.org\/10.1200\/jco.2014.57.9151.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1945_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00268-017-4234-x","volume":"42","author":"M Kanda","year":"2018","unstructured":"Kanda M, Tanaka C, Kobayashi D, et al. Preoperative albumin-bilirubin grade predicts recurrences after radical gastrectomy in patients with pT2-4 gastric cancer. World J Surg. 2018;42:773\u201381. https:\/\/doi.org\/10.1007\/s00268-017-4234-x.","journal-title":"World J Surg"},{"issue":"1","key":"1945_CR18","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1038\/s41598-022-19329-8","volume":"12","author":"HG Lee","year":"2022","unstructured":"Lee HG, Lim SB, Lee JL, et al. Preoperative albumin-bilirubin score as a prognostic indicator in patients with stage III colon cancer. Sci Rep. 2022;12:14910. https:\/\/doi.org\/10.1038\/s41598-022-19329-8.","journal-title":"Sci Rep"},{"issue":"4","key":"1945_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101038","volume":"14","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xu Q, Zhang H, et al. High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas. Transl Oncol. 2021;14:101038. https:\/\/doi.org\/10.1016\/j.tranon.2021.101038.","journal-title":"Transl Oncol"},{"key":"1945_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1945_CR21","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"1","key":"1945_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12885-023-11488-9","volume":"23","author":"H Xu","year":"2023","unstructured":"Xu H, Cao D, Zhou D, et al. Baseline albumin-bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis. BMC Cancer. 2023;23:1006. https:\/\/doi.org\/10.1186\/s12885-023-11488-9.","journal-title":"BMC Cancer"},{"key":"1945_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https:\/\/doi.org\/10.1186\/1745-6215-8-16.","journal-title":"Trials"},{"key":"1945_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1611175","volume":"29","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang X, Wu B, et al. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation. Pathol Oncol Res. 2023;29:1611175. https:\/\/doi.org\/10.3389\/pore.2023.1611175.","journal-title":"Pathol Oncol Res"},{"issue":"28","key":"1945_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000020654","volume":"99","author":"TN Zhang","year":"2020","unstructured":"Zhang TN, Yin RH, Wang LW. The prognostic and predictive value of the albumin-bilirubin score in advanced pancreatic cancer. Medicine (Baltimore). 2020;99:e20654. https:\/\/doi.org\/10.1097\/md.0000000000020654.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1945_CR26","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1245\/s10434-021-09593-9","volume":"28","author":"T Imamura","year":"2021","unstructured":"Imamura T, Okamura Y, Sugiura T, et al. Clinical significance of preoperative albumin-bilirubin grade in pancreatic cancer. Ann Surg Oncol. 2021;28:6223\u201335. https:\/\/doi.org\/10.1245\/s10434-021-09593-9.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1945_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14216\/kjco.23003","volume":"19","author":"CH Kwon","year":"2023","unstructured":"Kwon CH, Seo HI, Kim DU, et al. Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer. Korean J Clin Oncol. 2023;19:11\u20137. https:\/\/doi.org\/10.14216\/kjco.23003.","journal-title":"Korean J Clin Oncol"},{"issue":"4","key":"1945_CR28","first-page":"1941","volume":"25","author":"A Sakin","year":"2020","unstructured":"Sakin A, Sahin S, Sakin A, et al. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis. J buon. 2020;25:1941\u20136.","journal-title":"J buon"},{"issue":"6","key":"1945_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102048","volume":"8","author":"JM Berger","year":"2023","unstructured":"Berger JM, Alany A, Berchtold L, et al. Prognosticators of survival in patients with metastatic pancreatic cancer and ascites. ESMO Open. 2023;8:102048. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102048.","journal-title":"ESMO Open"},{"issue":"7","key":"1945_CR30","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.47391\/jpma.2413","volume":"72","author":"E Fidan","year":"2022","unstructured":"Fidan E, Yildirim A, Kazaz N, Fidan S, Cekic AB. The relationship between albumin-bilirubin score and survival in patients operated for pancreatic cancer. J Pak Med Assoc. 2022;72:1340\u20134. https:\/\/doi.org\/10.47391\/jpma.2413.","journal-title":"J Pak Med Assoc"},{"issue":"12","key":"1945_CR31","doi-asserted-by":"publisher","first-page":"e50949","DOI":"10.7759\/cureus.50949","volume":"15","author":"A Mejia","year":"2023","unstructured":"Mejia A, Vivian E, Shah J, Barrera Gutierrez JC. Albumin-bilirubin (ALBI) score and systemic immune-inflammation indexes used as pretreatment outcome predictors in patients with pancreatic ductal adenocarcinoma undergoing robotic or open Whipple procedures: a logistic regression analysis. Cureus. 2023;15:e50949. https:\/\/doi.org\/10.7759\/cureus.50949.","journal-title":"Cureus"},{"issue":"36","key":"1945_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000035069","volume":"102","author":"C Azili","year":"2023","unstructured":"Azili C, Tamam S, Benk MS, Deryol R, Culcu S, Unal AE. Preoperative ALBI grade predicts mortality in patients undergoing curative surgery for pancreatic head cancer. Medicine (Baltimore). 2023;102:e35069. https:\/\/doi.org\/10.1097\/md.0000000000035069.","journal-title":"Medicine (Baltimore)"},{"key":"1945_CR33","doi-asserted-by":"publisher","unstructured":"Ay S, Atci M, Arikan R, D\u00fclgar \u00d6, Tataro\u011flu \u00d6zy\u00fckseler D, G\u00fcm\u00fc\u015f M. Initial albumin-bilirubin grade as a prognostic indicator of pancreatic cancer with liver metastasis. J Oncol Sci. 2023;9:8\u201314. https:\/\/doi.org\/10.37047\/jos.2021-87242.","DOI":"10.37047\/jos.2021-87242"},{"issue":"3","key":"1945_CR34","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.21873\/anticanres.13260","volume":"39","author":"T Yagyu","year":"2019","unstructured":"Yagyu T, Saito H, Sakamoto T, et al. Preoperative albumin-bilirubin grade as a useful prognostic indicator in patients with pancreatic cancer. Anticancer Res. 2019;39:1441\u20136. https:\/\/doi.org\/10.21873\/anticanres.13260.","journal-title":"Anticancer Res"},{"key":"1945_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","journal-title":"Cancer Lett"},{"issue":"12","key":"1945_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.3617","volume":"153","author":"S van Roessel","year":"2018","unstructured":"van Roessel S, Kasumova GG, Verheij J, et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 2018;153:e183617. https:\/\/doi.org\/10.1001\/jamasurg.2018.3617.","journal-title":"JAMA Surg"},{"issue":"1","key":"1945_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.sla.0000259391.84304.2b","volume":"246","author":"CP Raut","year":"2007","unstructured":"Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52\u201360. https:\/\/doi.org\/10.1097\/01.sla.0000259391.84304.2b.","journal-title":"Ann Surg"},{"issue":"3","key":"1945_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00006676-200304000-00007","volume":"26","author":"S Takai","year":"2003","unstructured":"Takai S, Satoi S, Toyokawa H, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243\u20139. https:\/\/doi.org\/10.1097\/00006676-200304000-00007.","journal-title":"Pancreas"},{"issue":"9","key":"1945_CR39","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1245\/s10434-010-1071-7","volume":"17","author":"N Wasif","year":"2010","unstructured":"Wasif N, Ko CY, Farrell J, et al. Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010;17:2312\u201320. https:\/\/doi.org\/10.1245\/s10434-010-1071-7.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1945_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107589","volume":"26","author":"Y Liang","year":"2023","unstructured":"Liang Y, Cui J, Ding F, et al. A new staging system for postoperative prognostication in pancreatic ductal adenocarcinoma. iScience. 2023;26:107589. https:\/\/doi.org\/10.1016\/j.isci.2023.107589.","journal-title":"iScience"},{"issue":"5","key":"1945_CR41","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00330-019-06600-2","volume":"30","author":"T Xie","year":"2020","unstructured":"Xie T, Wang X, Li M, Tong T, Yu X, Zhou Z. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Eur Radiol. 2020;30:2513\u201324. https:\/\/doi.org\/10.1007\/s00330-019-06600-2.","journal-title":"Eur Radiol"},{"issue":"9","key":"1945_CR42","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","volume":"21","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21:2807\u201315. https:\/\/doi.org\/10.3748\/wjg.v21.i9.2807.","journal-title":"World J Gastroenterol"},{"key":"1945_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2018.01.024","volume":"479","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Wei Q, Fan J, Cheng S, Ding W, Hua Z. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis containing 8252 patients. Clin Chim Acta. 2018;479:181\u20139.","journal-title":"Clin Chim Acta"},{"key":"1945_CR44","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2147\/OTT.S154162","volume":"11","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Cheng S, Fathy AH, Qian H, Zhao Y. Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies. Onco Targets Ther. 2018;11:1899\u2013908.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"1945_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.21037\/gs-22-117","volume":"11","author":"R Han","year":"2022","unstructured":"Han R, Tian Z, Jiang Y, et al. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery. Gland Surg. 2022;11:576\u201387. https:\/\/doi.org\/10.21037\/gs-22-117.","journal-title":"Gland Surg"},{"issue":"1","key":"1945_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12885-024-11948-w","volume":"24","author":"J Yang","year":"2024","unstructured":"Yang J, Zhou H, Li H, Zhao F, Tong K. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study. BMC Cancer. 2024;24:193. https:\/\/doi.org\/10.1186\/s12885-024-11948-w.","journal-title":"BMC Cancer"},{"issue":"10","key":"1945_CR47","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1016\/j.transproceed.2019.08.027","volume":"51","author":"L Xu","year":"2019","unstructured":"Xu L, Wu J, Lu W, Yang C, Liu H. Application of the albumin-bilirubin grade in predicting the prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis. Transplant Proc. 2019;51:3338\u201346.","journal-title":"Transplant Proc"},{"issue":"3","key":"1945_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11901-020-00521-1","volume":"19","author":"M Tufoni","year":"2020","unstructured":"Tufoni M, Baldassarre M, Zaccherini G, Antognoli A, Caraceni P. Hemodynamic and systemic effects of albumin in patients with advanced liver disease. Curr Hepatol Rep. 2020;19:147\u201358.","journal-title":"Curr Hepatol Rep"},{"key":"1945_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.594574","volume":"11","author":"TD Hinds Jr.","year":"2020","unstructured":"Hinds TD Jr., Creeden JF, Gordon DM, Stec DF, Donald MC, Stec DE. Bilirubin nanoparticles reduce diet-induced hepatic steatosis, improve fat utilization, and increase plasma \u03b2-hydroxybutyrate. Front Pharmacol. 2020;11:594574. https:\/\/doi.org\/10.3389\/fphar.2020.594574.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1945_CR50","first-page":"164","volume":"95","author":"MV Fargo","year":"2017","unstructured":"Fargo MV, Grogan SP, Saguil A. Evaluation of jaundice in adults. Am Fam Physician. 2017;95:164\u20138.","journal-title":"Am Fam Physician"},{"issue":"1","key":"1945_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049325","volume":"12","author":"S Han","year":"2022","unstructured":"Han S, Wang C, Tong F, Li Y, Li Z, Sun Z. Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study. BMJ Open. 2022;12:e049325. https:\/\/doi.org\/10.1136\/bmjopen-2021-049325.","journal-title":"BMJ Open"},{"key":"1945_CR52","doi-asserted-by":"publisher","DOI":"10.5543\/tkda.2023.04488","author":"A Sungur","year":"2023","unstructured":"Sungur A, Sungur MA, Y\u0131ld\u0131r\u0131mt\u00fcrk \u00d6. Effect of albumin-bilirubin score on prognosis in ambulatory heart failure patients with reduced ejection fraction. Turk Kardiyol Dern Ars. 2023. https:\/\/doi.org\/10.5543\/tkda.2023.04488.","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"12","key":"1945_CR53","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.21037\/apm-21-3424","volume":"10","author":"Y Luo","year":"2021","unstructured":"Luo Y, Li Z, Liu J, Chong Y, Wu B. Prognostic value of the albumin-bilirubin score in critically ill patients with heart failure. Ann Palliat Med. 2021;10:12727\u201341. https:\/\/doi.org\/10.21037\/apm-21-3424.","journal-title":"Ann Palliat Med"},{"issue":"15","key":"1945_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34697","volume":"10","author":"E Gou","year":"2024","unstructured":"Gou E, Yang Q, Chen J, et al. Association between albumin-bilirubin score and in-hospital mortality in patients with sepsis: evidence from two large databases. Heliyon. 2024;10:e34697. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34697.","journal-title":"Heliyon"},{"key":"1945_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1412709","volume":"2024","author":"C Yang","year":"2024","unstructured":"Yang C, Yu Z, Peng B, Mao C, Li J, Cao Y. ALBI grade is associated with clinical outcomes of critically ill patients with AKI: a cohort study with Cox regression and propensity score matching. Mediators Inflamm. 2024;2024:1412709. https:\/\/doi.org\/10.1155\/2024\/1412709.","journal-title":"Mediators Inflamm"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01945-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:42:52Z","timestamp":1787132572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01945-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01945-7","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MOK, MM, IMO, FM and AA\u00a0declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a systematic review and meta-analysis, our study did not require any human participation and referral to our ethics committee.","order":2,"name":"Ethics","label":"Ethical approval and consent to participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a systematic review and meta-analysis, our study did not require any human participation.","order":3,"name":"Ethics","label":"Human ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/\u00a0publishers are responsible for the results\/findings and content of this article.","order":5,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}]}}